Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AGfiledCriticalBayer Pharma AG
Priority claimed from PCT/EP2014/077862external-prioritypatent/WO2015091414A2/de
Publication of MA39122A1publicationCriticalpatent/MA39122A1/fr
Publication of MA39122B1publicationCriticalpatent/MA39122B1/fr
Inhibidor del sistema complemento de ornithodoros moubata para utilizarse en el tratamiento de enfermedades mediadas por el sistema complemento en pacientes con polimorfismo de c5.
N-[4-(quinolin-4-yloxy)cyclohexyl(méthyl)](hétéro)arylcarboxamides utilisables en tant qu'antagonistes des récepteurs aux androgènes, leur production et leur utilisation en tant que médicaments